Peritoneal progression after pancreaticoduodenectomy is a devastating surgical treatment failure: HIPEC gemcitabine is an option.
作者信息
Sugarbaker Paul H, Van der Speeten Kurt
机构信息
MedStar Washington Hospital Center, Washington, DC, USA.
Department of Surgery, Hospital Oost-Limburg, Genk, Belgium.
出版信息
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S118-S119. doi: 10.21037/jgo-2020-14.
Abstract
摘要
相似文献
1
Peritoneal progression after pancreaticoduodenectomy is a devastating surgical treatment failure: HIPEC gemcitabine is an option.胰十二指肠切除术后腹膜转移是一种严重的手术治疗失败情况：腹腔内热灌注化疗联合吉西他滨是一种选择。
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S118-S119. doi: 10.21037/jgo-2020-14.
2
Strategies to improve local control of resected pancreas adenocarcinoma.改善切除的胰腺腺癌局部控制的策略。
Surg Oncol. 2017 Mar;26(1):63-70. doi: 10.1016/j.suronc.2017.01.002. Epub 2017 Jan 18.
3
Ten-year survival of pancreas cancer with liver metastases treated by intraoperative and long-term intraperitoneal gemcitabine. A case report.术中及长期腹腔内应用吉西他滨治疗伴肝转移胰腺癌的10年生存率。病例报告。
Int J Surg Case Rep. 2023 Jun;107:108313. doi: 10.1016/j.ijscr.2023.108313. Epub 2023 May 9.
4
The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4.在胰腺腹膜癌病实验模型中，吉西他滨腹腔内热化疗对肿瘤进展的抑制作用，及其与胰腺癌干细胞CD133 + CXCR4的关系。
Pancreatology. 2016 Jul-Aug;16(4):632-9. doi: 10.1016/j.pan.2016.04.031. Epub 2016 May 12.
5
Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer.细胞减灭术联合腹腔热灌注化疗治疗胰腺癌腹膜转移癌
J BUON. 2018 Mar-Apr;23(2):482-487.
6
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.胃癌患者腹膜播散的细胞减灭术和腹腔内热灌注化疗（HIPEC）治疗：PERISCOPE研究的原理与设计
JMIR Res Protoc. 2017 Jul 13;6(7):e136. doi: 10.2196/resprot.7790.
7
Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol and recommended future directions.腹腔内吉西他滨化疗对已切除胰腺癌患者是安全的：来自一项II期方案的最终临床和药理学数据及推荐的未来研究方向
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S99-S109. doi: 10.21037/jgo-2020-02.
8
[A surgical case of peritoneal dissemination metastasis of bile duct carcinoma after pancreaticoduodenectomy].
Gan To Kagaku Ryoho. 2013 Nov;40(12):1771-3.
9
Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model.多模态方法在荷瘤大鼠模型中治疗腹膜表面恶性肿瘤。
Int J Colorectal Dis. 2010 Feb;25(2):245-50. doi: 10.1007/s00384-009-0819-7. Epub 2009 Nov 10.
10
Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer.胃癌腹膜转移患者在诱导化疗有反应后行腹腔热灌注化疗手术。
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S47-S56. doi: 10.21037/jgo-20-121.
本文引用的文献
1
Conversion surgery in patients with pancreatic cancer and peritoneal metastasis.胰腺癌伴腹膜转移患者的转化手术
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S110-S117. doi: 10.21037/jgo-20-243.
2
Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol and recommended future directions.腹腔内吉西他滨化疗对已切除胰腺癌患者是安全的：来自一项II期方案的最终临床和药理学数据及推荐的未来研究方向
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S99-S109. doi: 10.21037/jgo-2020-02.
3
Hyperthermic intra-operative intraperitoneal chemotherapy as an adjuvant to pancreatic cancer resection.术中腹腔内热灌注化疗作为胰腺癌切除的辅助治疗方法
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S91-S98. doi: 10.21037/jgo-20-46.
4
Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-41.吉西他滨围手术期热灌注腹腔化疗在可切除胰腺腺癌患者中的安全性：临床试验EudraCT 2016 - 004298 - 41的一项初步研究
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S80-S90. doi: 10.21037/jgo-20-238.
Zotero 插件